Gilead Sciences, Inc. vs United Microelectronics Corp — how do they compare? Gilead Sciences, Inc. trades at $135.47 (market cap $168.35B), while United Microelectronics Corp trades at $19.58 (market cap $47.81B). The key difference: Gilead Sciences, Inc. is far larger — about 3.5× United Microelectronics Corp's market cap, and Gilead Sciences, Inc. pays the higher dividend (2.42%). Which is the better fit depends on your goals.
| GILD | UMC | |
|---|---|---|
Market Cap | $168.35B | $47.81B |
Sector | Health | Technology |
52-Week High | $155.80 | $28.02 |
52-Week Low | $110.56 | $6.58 |
Enterprise Value | $191.42B | $44.93B |
Dividend Yield | 2.42% | 2.12% |
Trailing returns across standard periods
Latest headlines on both assets
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Read more on GILD →Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 7% market share in 2021, according to Gartner, after TSMC and GlobalFoundries. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the U.S. and South Korea. UMC features a diverse customer base including Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.
Read more on UMC →